Primary information |
---|
CancerPDF_ID | CancerPDF_ID12682 |
PMID | 25168216 |
Peptide Sequence | APKPHAFVGSVK |
Peptide Sequence in Publication | APKPHAFVGSVK |
Protein Name | Putative Polycombgroup Protein ASXL1 |
UniprotKB Entry Name | EZH2_HUMAN |
Biofluid | Serum |
M/Z | NA |
Charge | NA |
Mass/H+ | NA |
Mass (in Daltons) | 1236.69 |
Profiling Technique | LC-MS |
Peptide Identification Technique | LC-MS/MS |
Quantification Technique | NA |
Labeling | Label Free |
FDR | NA |
p-Value | 1.86E_05 |
Software | MASCOT |
Length of Peptide | 12 |
Cancer Type | Renal cell carcinaoma |
Database for Peptide search | SwissProt Database |
Modification | NA |
Number of Patients | "30 RCC patients and 30 healthy controls for training dataset and 6 RCC patients, 6 control in independent validation dataset" |
Regulation/Differential Expression | Upregulated in cancer v/s Normal |
Validation | Independent validation |
Sensitivity | 100 % (for 19 peptide signatures) |
Specificity | NA |
Accuracy | AUC : 0.832 |
Secondary information |
---|
Peptide Atlas | NA |
IEDB | |